“…20, 28,29,30,53,54,62,63,65 In February 1989 it was used successfully to salvage 8 of 10 liver allograft recipients suffering intractable rejection despite optimal cydosporinebased immunotherapy. 50 Further use for this indication accrued over 200 patients, and was expanded to include recipients of heart, kidney, lung, and pancreas allografts.…”